GSK's Stiefel begins study on rare skin disease
October 07, 2014 at 09:30 AM EDT
Stiefel, a GSK company, began a study on a drug’s effectiveness in fighting pemphigus vulgaris, a rare autoimmune skin disorder...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.